Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of colchicine in treatment of coronavirus
IRCT20200418047126N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- May 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of colchicine in coronavirus disease 2019 (COVID-19) and pneumonia, sponsored by Ardabil University of Medical Sciences. Started May 2020; status: completed.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on IRCT20200418047126N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200418047126N1.